Cite

HARVARD Citation

    Edman Kessler, L. et al. (2020). Efficacy and safety of cyclin dependent kinases 4/6 inhibitors in the treatment of metastatic breast cancer: a real-world experience. Acta oncologica. pp. 1382-1387. [Online]. 
  
Back to record